This course has expired. View available courses.
Cardiology, Screening & Prevention
Direct Oral Anticoagulants (DOACs) in the Elderly
Increasing age is an established risk factor for both atrial fibrillation (AF) and venous thromboembolism (VTE), and the risk of stroke from AF is over 20% in people aged 80 and over. Elderly patients do bleed more than younger patients even when not on oral anticoagulants (OACs), and physicians tend to be more reluctant to prescribe OACs to their older patients. However, clinical trials have shown that elderly patients with AF derive a greater net clinical benefit from anticoagulation than the younger patients that physicians are more inclined to treat.
Listen to Dr. Veenhuyzen and Dr. Cho discuss the risks and benefits, as well as the safety and efficacy of OACs to prevent stroke in elderly patients with AF. They will also address common concerns when starting OACs in the elderly population, such as concomitant medications, fall risk, adherence, and renal impairment.
This program is made possible through educational support from the BMS/Pfizer Alliance.
DURATION
20 mins
PROFESSION
Physician
# OF CREDITS
0.25
ACCREDITATION
Mainpro+
EXPIRY DATE
2022-09-20
Increasing age is an established risk factor for both atrial fibrillation (AF) and venous thromboembolism (VTE), and the risk of stroke from AF is over 20% in people aged 80 and over. Elderly patients do bleed more than younger patients even when not on oral anticoagulants (OACs), and physicians tend to be more reluctant to prescribe OACs to their older patients. However, clinical trials have shown that elderly patients with AF derive a greater net clinical benefit from anticoagulation than the younger patients that physicians are more inclined to treat.
Listen to Dr. Veenhuyzen and Dr. Cho discuss the risks and benefits, as well as the safety and efficacy of OACs to prevent stroke in elderly patients with AF. They will also address common concerns when starting OACs in the elderly population, such as concomitant medications, fall risk, adherence, and renal impairment.
This program is made possible through educational support from the BMS/Pfizer Alliance.
Faculty
George D. Veenhuyzen, MD, FRCPC
Kenneth Cho, MD
Sy Lam, MD
Anas Nsier, MD
Parmjit Sohal, MD
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Describe the risks and benefits of oral anticoagulation therapy for elderly patients with atrial fibrillation (AF);
- Describe the efficacy and safety of oral anticoagulation for stroke prevention in elderly patients with AF;
- Discuss common concerns when starting oral anticoagulation in the elderly population, such as concomitant medications, fall risk, adherence, and renal impairment.
Accreditation
This self-learning program has been certified by the College of Family Physicians of Canada for up to 0.25 Mainpro+ credits.
Cert+ Program ID#: 194824
#
of credits: 0.25
Duration: 20 mins
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
